USA Breast Cancer Liquid Biopsy Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Breast Cancer Liquid Biopsy market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Breast Cancer Liquid Biopsy market. Detailed analysis of key players, along with key growth strategies adopted by Breast Cancer Liquid Biopsy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • RainDance Technologies

    • MDx Health

    • Menarini Silicon Biosystems

    • Roche Diagnostics

    • Guardant Health

    • Thermo Fisher Scientific

    • Illumina

    • Trovagene

    • QIAGEN

    • Genomic Health

    • Biocept

    • Bio-Rad Laboratories

    • Myriad Genetics

    By Type:

    • Circulating Tumor Cells (CTCs)

    • Cell-Free DNA (CfDNA)

    • Extracellular Vesicles (EVs)

    • Other Circulating Biomarkers

    By End-User:

    • Hospitals

    • Diagnostic Centers

    • Laboratories

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Breast Cancer Liquid Biopsy Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Circulating Tumor Cells (CTCs) from 2016 to 2027

      • 1.3.2 USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Cell-Free DNA (CfDNA) from 2016 to 2027

      • 1.3.3 USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Extracellular Vesicles (EVs) from 2016 to 2027

      • 1.3.4 USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Other Circulating Biomarkers from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Hospitals from 2016 to 2027

      • 1.4.2 USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Diagnostic Centers from 2016 to 2027

      • 1.4.3 USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Laboratories from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Breast Cancer Liquid Biopsy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Breast Cancer Liquid Biopsy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Breast Cancer Liquid Biopsy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Breast Cancer Liquid Biopsy Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Breast Cancer Liquid Biopsy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Breast Cancer Liquid Biopsy by Major Types

      • 3.4.1 Market Size and Growth Rate of Circulating Tumor Cells (CTCs)

      • 3.4.2 Market Size and Growth Rate of Cell-Free DNA (CfDNA)

      • 3.4.3 Market Size and Growth Rate of Extracellular Vesicles (EVs)

      • 3.4.4 Market Size and Growth Rate of Other Circulating Biomarkers

    4 Segmentation of Breast Cancer Liquid Biopsy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Breast Cancer Liquid Biopsy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Breast Cancer Liquid Biopsy in Hospitals

      • 4.4.2 Market Size and Growth Rate of Breast Cancer Liquid Biopsy in Diagnostic Centers

      • 4.4.3 Market Size and Growth Rate of Breast Cancer Liquid Biopsy in Laboratories

    5 Market Analysis by Regions

    • 5.1 USA Breast Cancer Liquid Biopsy Production Analysis by Regions

    • 5.2 USA Breast Cancer Liquid Biopsy Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Breast Cancer Liquid Biopsy Landscape Analysis

    • 6.1 West USA Breast Cancer Liquid Biopsy Landscape Analysis by Major Types

    • 6.2 West USA Breast Cancer Liquid Biopsy Landscape Analysis by Major End-Users

    7 South USA Breast Cancer Liquid Biopsy Landscape Analysis

    • 7.1 South USA Breast Cancer Liquid Biopsy Landscape Analysis by Major Types

    • 7.2 South USA Breast Cancer Liquid Biopsy Landscape Analysis by Major End-Users

    8 Middle West USA Breast Cancer Liquid Biopsy Landscape Analysis

    • 8.1 Middle West USA Breast Cancer Liquid Biopsy Landscape Analysis by Major Types

    • 8.2 Middle West USA Breast Cancer Liquid Biopsy Landscape Analysis by Major End-Users

    9 Northeast USA Breast Cancer Liquid Biopsy Landscape Analysis

    • 9.1 Northeast USA Breast Cancer Liquid Biopsy Landscape Analysis by Major Types

    • 9.2 Northeast USA Breast Cancer Liquid Biopsy Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 RainDance Technologies

        • 10.1.1 RainDance Technologies Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 MDx Health

        • 10.2.1 MDx Health Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Menarini Silicon Biosystems

        • 10.3.1 Menarini Silicon Biosystems Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Roche Diagnostics

        • 10.4.1 Roche Diagnostics Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Guardant Health

        • 10.5.1 Guardant Health Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Thermo Fisher Scientific

        • 10.6.1 Thermo Fisher Scientific Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Illumina

        • 10.7.1 Illumina Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Trovagene

        • 10.8.1 Trovagene Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 QIAGEN

        • 10.9.1 QIAGEN Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Genomic Health

        • 10.10.1 Genomic Health Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Biocept

        • 10.11.1 Biocept Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Bio-Rad Laboratories

        • 10.12.1 Bio-Rad Laboratories Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Myriad Genetics

        • 10.13.1 Myriad Genetics Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Circulating Tumor Cells (CTCs) from 2016 to 2027

    • Figure USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Cell-Free DNA (CfDNA) from 2016 to 2027

    • Figure USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Extracellular Vesicles (EVs) from 2016 to 2027

    • Figure USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Other Circulating Biomarkers from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Diagnostic Centers from 2016 to 2027

    • Figure USA Breast Cancer Liquid Biopsy Market Size and Growth Rate of Laboratories from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Breast Cancer Liquid Biopsy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Breast Cancer Liquid Biopsy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Breast Cancer Liquid Biopsy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Breast Cancer Liquid Biopsy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Breast Cancer Liquid Biopsy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Breast Cancer Liquid Biopsy

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Breast Cancer Liquid Biopsy by Different Types from 2016 to 2027

    • Table Consumption Share of Breast Cancer Liquid Biopsy by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Circulating Tumor Cells (CTCs)

    • Figure Market Size and Growth Rate of Cell-Free DNA (CfDNA)

    • Figure Market Size and Growth Rate of Extracellular Vesicles (EVs)

    • Figure Market Size and Growth Rate of Other Circulating Biomarkers

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Breast Cancer Liquid Biopsy by Different End-Users from 2016 to 2027

    • Table Consumption Share of Breast Cancer Liquid Biopsy by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Diagnostic Centers

    • Figure Market Size and Growth Rate of Laboratories

    • Table USA Breast Cancer Liquid Biopsy Production by Regions

    • Table USA Breast Cancer Liquid Biopsy Production Share by Regions

    • Figure USA Breast Cancer Liquid Biopsy Production Share by Regions in 2016

    • Figure USA Breast Cancer Liquid Biopsy Production Share by Regions in 2021

    • Figure USA Breast Cancer Liquid Biopsy Production Share by Regions in 2027

    • Table USA Breast Cancer Liquid Biopsy Consumption by Regions

    • Table USA Breast Cancer Liquid Biopsy Consumption Share by Regions

    • Figure USA Breast Cancer Liquid Biopsy Consumption Share by Regions in 2016

    • Figure USA Breast Cancer Liquid Biopsy Consumption Share by Regions in 2021

    • Figure USA Breast Cancer Liquid Biopsy Consumption Share by Regions in 2027

    • Table West USA Breast Cancer Liquid Biopsy Consumption by Types from 2016 to 2027

    • Table West USA Breast Cancer Liquid Biopsy Consumption Share by Types from 2016 to 2027

    • Figure West USA Breast Cancer Liquid Biopsy Consumption Share by Types in 2016

    • Figure West USA Breast Cancer Liquid Biopsy Consumption Share by Types in 2021

    • Figure West USA Breast Cancer Liquid Biopsy Consumption Share by Types in 2027

    • Table West USA Breast Cancer Liquid Biopsy Consumption by End-Users from 2016 to 2027

    • Table West USA Breast Cancer Liquid Biopsy Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Breast Cancer Liquid Biopsy Consumption Share by End-Users in 2016

    • Figure West USA Breast Cancer Liquid Biopsy Consumption Share by End-Users in 2021

    • Figure West USA Breast Cancer Liquid Biopsy Consumption Share by End-Users in 2027

    • Table South USA Breast Cancer Liquid Biopsy Consumption by Types from 2016 to 2027

    • Table South USA Breast Cancer Liquid Biopsy Consumption Share by Types from 2016 to 2027

    • Figure South USA Breast Cancer Liquid Biopsy Consumption Share by Types in 2016

    • Figure South USA Breast Cancer Liquid Biopsy Consumption Share by Types in 2021

    • Figure South USA Breast Cancer Liquid Biopsy Consumption Share by Types in 2027

    • Table South USA Breast Cancer Liquid Biopsy Consumption by End-Users from 2016 to 2027

    • Table South USA Breast Cancer Liquid Biopsy Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Breast Cancer Liquid Biopsy Consumption Share by End-Users in 2016

    • Figure South USA Breast Cancer Liquid Biopsy Consumption Share by End-Users in 2021

    • Figure South USA Breast Cancer Liquid Biopsy Consumption Share by End-Users in 2027

    • Table Middle West USA Breast Cancer Liquid Biopsy Consumption by Types from 2016 to 2027

    • Table Middle West USA Breast Cancer Liquid Biopsy Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Breast Cancer Liquid Biopsy Consumption Share by Types in 2016

    • Figure Middle West USA Breast Cancer Liquid Biopsy Consumption Share by Types in 2021

    • Figure Middle West USA Breast Cancer Liquid Biopsy Consumption Share by Types in 2027

    • Table Middle West USA Breast Cancer Liquid Biopsy Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Breast Cancer Liquid Biopsy Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Breast Cancer Liquid Biopsy Consumption Share by End-Users in 2016

    • Figure Middle West USA Breast Cancer Liquid Biopsy Consumption Share by End-Users in 2021

    • Figure Middle West USA Breast Cancer Liquid Biopsy Consumption Share by End-Users in 2027

    • Table Northeast USA Breast Cancer Liquid Biopsy Consumption by Types from 2016 to 2027

    • Table Northeast USA Breast Cancer Liquid Biopsy Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Breast Cancer Liquid Biopsy Consumption Share by Types in 2016

    • Figure Northeast USA Breast Cancer Liquid Biopsy Consumption Share by Types in 2021

    • Figure Northeast USA Breast Cancer Liquid Biopsy Consumption Share by Types in 2027

    • Table Northeast USA Breast Cancer Liquid Biopsy Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Breast Cancer Liquid Biopsy Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Breast Cancer Liquid Biopsy Consumption Share by End-Users in 2016

    • Figure Northeast USA Breast Cancer Liquid Biopsy Consumption Share by End-Users in 2021

    • Figure Northeast USA Breast Cancer Liquid Biopsy Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of RainDance Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of RainDance Technologies

    • Figure Sales and Growth Rate Analysis of RainDance Technologies

    • Figure Revenue and Market Share Analysis of RainDance Technologies

    • Table Product and Service Introduction of RainDance Technologies

    • Table Company Profile and Development Status of MDx Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MDx Health

    • Figure Sales and Growth Rate Analysis of MDx Health

    • Figure Revenue and Market Share Analysis of MDx Health

    • Table Product and Service Introduction of MDx Health

    • Table Company Profile and Development Status of Menarini Silicon Biosystems

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Menarini Silicon Biosystems

    • Figure Sales and Growth Rate Analysis of Menarini Silicon Biosystems

    • Figure Revenue and Market Share Analysis of Menarini Silicon Biosystems

    • Table Product and Service Introduction of Menarini Silicon Biosystems

    • Table Company Profile and Development Status of Roche Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Diagnostics

    • Figure Sales and Growth Rate Analysis of Roche Diagnostics

    • Figure Revenue and Market Share Analysis of Roche Diagnostics

    • Table Product and Service Introduction of Roche Diagnostics

    • Table Company Profile and Development Status of Guardant Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guardant Health

    • Figure Sales and Growth Rate Analysis of Guardant Health

    • Figure Revenue and Market Share Analysis of Guardant Health

    • Table Product and Service Introduction of Guardant Health

    • Table Company Profile and Development Status of Thermo Fisher Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table Product and Service Introduction of Thermo Fisher Scientific

    • Table Company Profile and Development Status of Illumina

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina

    • Figure Sales and Growth Rate Analysis of Illumina

    • Figure Revenue and Market Share Analysis of Illumina

    • Table Product and Service Introduction of Illumina

    • Table Company Profile and Development Status of Trovagene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Trovagene

    • Figure Sales and Growth Rate Analysis of Trovagene

    • Figure Revenue and Market Share Analysis of Trovagene

    • Table Product and Service Introduction of Trovagene

    • Table Company Profile and Development Status of QIAGEN

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of QIAGEN

    • Figure Sales and Growth Rate Analysis of QIAGEN

    • Figure Revenue and Market Share Analysis of QIAGEN

    • Table Product and Service Introduction of QIAGEN

    • Table Company Profile and Development Status of Genomic Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health

    • Figure Sales and Growth Rate Analysis of Genomic Health

    • Figure Revenue and Market Share Analysis of Genomic Health

    • Table Product and Service Introduction of Genomic Health

    • Table Company Profile and Development Status of Biocept

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocept

    • Figure Sales and Growth Rate Analysis of Biocept

    • Figure Revenue and Market Share Analysis of Biocept

    • Table Product and Service Introduction of Biocept

    • Table Company Profile and Development Status of Bio-Rad Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Rad Laboratories

    • Figure Sales and Growth Rate Analysis of Bio-Rad Laboratories

    • Figure Revenue and Market Share Analysis of Bio-Rad Laboratories

    • Table Product and Service Introduction of Bio-Rad Laboratories

    • Table Company Profile and Development Status of Myriad Genetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad Genetics

    • Figure Sales and Growth Rate Analysis of Myriad Genetics

    • Figure Revenue and Market Share Analysis of Myriad Genetics

    • Table Product and Service Introduction of Myriad Genetics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.